FDA Inspection 840220 — San Diego Blood Bank

San Diego Blood Bank — FEI 2075359

The FDA completed an inspection of San Diego Blood Bank on July 12, 2013 in San Diego, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 12, 2013
Fiscal Year
2013
Product Type
Biologics
Project Area
Blood and Blood Products
Location
San Diego, CA (United States)

Citations

IDCFRDescription
4121 CFR 606.40(a)(1)Provide space for examination
9821 CFR 606.100(c)Thorough investigations